Showing results (121-130 of 232) with videos related to

Sort By:
Pageof 24
Molecular & Cellular Proteomics : MCP|September 9, 2006
Transgenic mouse proteomics identifies new 14-3-3-associated proteins involved in cytoskeletal rearrangements and cell signalingPierre-Olivier Angrand, Inmaculada Segura, Pamela Völkel, et al.
Nature Chemical Biology|March 2, 2010
A chemical and phosphoproteomic characterization of dasatinib action in lung cancerJiannong Li, Uwe Rix, Bin Fang, et al.
Blood|August 28, 2007
Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targetsUwe Rix, Oliver Hantschel, Gerhard Dürnberger, et al.
Oncotarget|April 19, 2017
TKI rotation-induced persistent deep molecular response in multi-resistant blast crisis of Ph+ CMLPeter Valent, Susanne Herndlhofer, Mathias Schneeweiß, et al.
Cell Chemical Biology|January 4, 2025
The efflux pump ABCC1/MRP1 constitutively restricts PROTAC sensitivity in cancer cellsGernot Wolf, Conner Craigon, Shao Thing Teoh, et al.
Blood|June 4, 2010
BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinibDaniel W Sherbenou, Oliver Hantschel, Ines Kaupe, et al.
ACS Chemical Biology|December 15, 2023
Discovery of Molecular Glue Degraders via Isogenic Morphological ProfilingAmanda Ng, Fabian Offensperger, Jose A Cisneros, et al.
Arthritis and Rheumatism|February 16, 2010
Antiinflammatory effects of tumor necrosis factor on hematopoietic cells in a murine model of erosive arthritisStephan Blüml, Nikolaus B Binder, Birgit Niederreiter, et al.
Plos One|September 21, 2011
Functional dissection of the TBK1 molecular networkAdriana Goncalves, Tilmann Bürckstümmer, Evelyn Dixit, et al.
Cell|October 18, 2011
Targeting the SH2-kinase interface in Bcr-Abl inhibits leukemogenesisFlorian Grebien, Oliver Hantschel, John Wojcik, et al.
Pageof 24